Aspirin is the foundational treatment for secondary prevention of cardiac events and the standard therapy I have used for my patients for decades, but it can expose some patients to bleeding risk. For each patient, I balance the benefit-risk ratio and tailor the aspirin (acetylsalicylic acid) therapy to the greatest response and adherence with the lowest risk for bleeding. A recent review article
PLx Pharma Inc. (NASDAQ:PLXP – Get Rating) CFO Rita M. O’connor bought 13,700 shares of the business’s stock in a transaction that occurred on Tuesday, March 15th. The shares were bought at an average cost of $3.66 per share, for a total transaction of $50,142.00. The transaction was disclosed in a filing with the Securities […]
PLx Pharma Inc. (NASDAQ:PLXP – Get Rating) CEO Natasha Giordano purchased 4,100 shares of PLx Pharma stock in a transaction that occurred on Tuesday, March 15th. The stock was bought at an average cost of $3.65 per share, with a total value of $14,965.00. The acquisition was disclosed in a document filed with the Securities […]
Read our preview of key economic and company events in the week ahead, including the ECB s interest rate decision, US CPI for February, and corporate earnings from Greggs, Rivian, and more.
Read our preview of key economic and company events in the week ahead, including the ECB s interest rate decision, US CPI for February, and corporate earnings from Greggs, Rivian, and more.